Aberrant MicroRNAs Expression Patterns in Pancreatic Cancer and Their Clinical Translation

被引：24

作者：

Du, Yiqi ^{[1
]}

Liu, Minghao ^{[1
]}

Gao, Jun ^{[1
]}

Li, Zhaoshen ^{[1
]}

机构：

[1] Second Mil Med Univ, Changhai Hosp, Dept Gastroenterol, Shanghai 200433, Peoples R China

来源：

CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS | 2013年 / 28卷 / 05期

基金：

中国国家自然科学基金;

关键词：

biomarker; early diagnosis; gene regulation; microRNA; oncogene; pancreatic cancer; CHRONIC LYMPHOCYTIC-LEUKEMIA; DUCTAL ADENOCARCINOMA; NUCLEAR EXPORT; BREAST-CANCER; MICROPROCESSOR COMPLEX; MESENCHYMAL TRANSITION; CELL-PROLIFERATION; GENE-EXPRESSION; INVASION; RNA;

D O I：

10.1089/cbr.2012.1389

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

Pancreatic cancer (PC) has a high rate of mortality and a poorly understood mechanism of progression. MicroRNA (miRNA) molecules have been proved to play an important role in malignant transformation and cancer development. Thousands of miRNAs have been screened in PC and several of them, such as miR-21, 155, and 196a, show up- or down-regulation that is associated with progression of the disease. However, the roles of these molecules in the regulation of tumorigenesis are not clear. Some studies have investigated whether circulating miRNAs could be detected in serum of patients with PC and whether expression levels of specific miRNAs differed between PC patients, pancreatitis patients, and healthy individuals. The current review focuses on this topic along with a possible role for miRNAs in the early diagnosis of PC.

引用

页码：361 / 369

页数：9

共 115 条

[1]

Abba Mohammed, 2009, DRUG DISCOV TODAY DI, V6, P13

[2]

miR-200 Expression Regulates Epithelial-to-Mesenchymal Transition in Bladder Cancer Cells and Reverses Resistance to Epidermal Growth Factor Receptor Therapy [J].

Adam, Liana ;

Zhong, Meng ;

Choi, Woonyoung ;

Qi, Wei ;

Nicoloso, Milena ;

Arora, Ameeta ;

Calin, George ;

Wang, Hua ;

Siefker-Radtke, Arlene ;

McConkey, David ;

Bar-Eli, Menashe ;

Dinney, Colin .

CLINICAL CANCER RESEARCH, 2009, 15 (16) :5060-5072

[3]

Albulescu R, 2011, EXPERT REV MOL DIAGN, V11, P101, DOI [10.1586/erm.10.106, 10.1586/ERM.10.106]

[4]

RETRACTED: Gemcitabine Sensitivity Can Be Induced in Pancreatic Cancer Cells through Modulation of miR-200 and miR-21 Expression by Curcumin or Its Analogue CDF (Retracted article. See vol. 78, pg. 5466, 2018) [J].

Ali, Shadan ;

Ahmad, Aamir ;

Banerjee, Sanjeev ;

Padhye, Subhash ;

Dominiak, Kristin ;

Schaffert, Jacqueline M. ;

Wang, Zhiwei ;

Philip, Philip A. ;

Sarkar, Fazlul H. .

CANCER RESEARCH, 2010, 70 (09) :3606-3617

[5]

Quantitation of microRNAs using a modified Invader assay [J].

Allawi, HT ;

Dahlberg, JE ;

Olson, S ;

Lund, E ;

Olson, M ;

Ma, WP ;

Takova, T ;

Neri, BP ;

Lyamichev, VI .

RNA, 2004, 10 (07) :1153-1161

[6]

The functions of animal microRNAs [J].

Ambros, V .

NATURE, 2004, 431 (7006) :350-355

[7]

Pancreatic cancer: Translational research aspects and clinical implications [J].

Ansari, Daniel ;

Chen, Bi-Cheng ;

Dong, Lei ;

Zhou, Meng-Tao ;

Andersson, Roland .

WORLD JOURNAL OF GASTROENTEROLOGY, 2012, 18 (13) :1417-1424

[8]

In vitro quantification of specific microRNA using molecular beacons [J].

Baker, Meredith B. ;

Bao, Gang ;

Searles, Charles D. .

NUCLEIC ACIDS RESEARCH, 2012, 40 (02) :e13

[9]

MicroRNAs: Genomics, biogenesis, mechanism, and function (Reprinted from Cell, vol 116, pg 281-297, 2004) [J].

Bartel, David P. .

CELL, 2007, 131 (04) :11-29

[10]

Diagnosis of Pancreatic Ductal Adenocarcinoma and Chronic Pancreatitis by Measurement of microRNA Abundance in Blood and Tissue [J].

Bauer, Andrea S. ;

Keller, Andreas ;

Costello, Eithne ;

Greenhalf, William ;

Bier, Melanie ;

Borries, Anne ;

Beier, Markus ;

Neoptolemos, John ;

Buechler, Markus ;

Werner, Jens ;

Giese, Nathalia ;

Hoheisel, Joerg D. .

PLOS ONE, 2012, 7 (04)

← 1 2 3 4 5 6 7 8 9 10 →